Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Company Profile

• Business description

  Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a biopharmaceutical company committed to the R&D, manufacturing, and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population. Currently, the company has two ADC drugs as Core Products, namely, sac-TMT and trastuzumab botidotin.

• Contact

  No. 666 Xinhua Avenue
  Chengdu Cross-Strait Science and Technology Industry Development Park
  Wenjiang
  Sichuan
  Chengdu
  CHN

  T: +86 4006887002

  https://www.kelun-biotech.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2026

  Employees

  2,045